2591 Share Price Performance
HK$43.78
-13.47 (-23.53%)
Price HK$43.78
Share Pricen/a
No recently updated narratives available.
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs. Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.